532872 Stock Overview
Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Sun Pharma Advanced Research Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹286.10 |
| 52 Week High | ₹474.00 |
| 52 Week Low | ₹178.10 |
| Beta | 0.74 |
| 1 Month Change | -23.70% |
| 3 Month Change | -23.20% |
| 1 Year Change | 43.66% |
| 3 Year Change | 62.79% |
| 5 Year Change | 69.74% |
| Change since IPO | 228.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532872 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -22.6% | -0.5% | 1.4% |
| 1Y | 43.7% | 55.3% | 46.1% |
Return vs Industry: 532872 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 532872 underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| 532872 volatility | |
|---|---|
| 532872 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532872's share price has been volatile over the past 3 months.
Volatility Over Time: 532872's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 407 | Anilkumar Raghavan | www.sparc.life |
Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, dermatology, and Immunology. The company offers Elepsia XR, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension; and Phenobarbital injection for the treatment of neonatal seizures.
Sun Pharma Advanced Research Company Limited Fundamentals Summary
| 532872 fundamental statistics | |
|---|---|
| Market cap | ₹97.41b |
| Earnings (TTM) | -₹3.63b |
| Revenue (TTM) | ₹1.07b |
86.7x
P/S Ratio-25.5x
P/E RatioIs 532872 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532872 income statement (TTM) | |
|---|---|
| Revenue | ₹1.07b |
| Cost of Revenue | ₹326.64m |
| Gross Profit | ₹740.16m |
| Other Expenses | ₹4.37b |
| Earnings | -₹3.63b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -11.20 |
| Gross Margin | 69.38% |
| Net Profit Margin | -340.66% |
| Debt/Equity Ratio | 4.3% |
How did 532872 perform over the long term?
See historical performance and comparison